• |
  • |
  • |
  • |
Donate

AUCD Experts

Jill Hollway, PhD

Login to Update Your Profile
Contact Information:
614-688-3848
Leadership:
Primary Activity Coordinators:
Research
Discipline Coordinators:
Discipline(s):
Psychology
AUCD Council Membership:
No Council Membership
Vita/Bio:
Service:
Linked Projects

Acetyl L-Carnitine
Long-Term Open Label Safety Study of Atomoxetine Hydrochloride in Patients 6 Years and Older with Attention-Deficit Disorder
Acetyl L-Carnitine
PHARM - Melatonin as a treatment for sleep disturbance in Autism Spectrum Disorders
PHARM - An open-label extension of the safety and tolerability of Memantine in pediatric patients with autism, Asperger's disorder or pervasive develo

PHARM - MEM-MD-91: An open-label study of the safety and tolerability of memantine in pediatric patients with Autism, Asperger's Disorder, or PDD-NOS
PHARM - A double blind, placebo-controlled, randomized withdrawal study of the safety and efficacy of memantine in pediatric patients with autism, Asp
PHARM- A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasido
PHARM- A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasido
PHARM - Essential Oils for Enhancing Quality of Life for Children in Autism Spectrum Disorder (ASD)
PHARM - An extension study to evaluate the safety and effectiveness of lurasidone in subjects with schizophrenia and autistic associated irritability
PHARM - 810P501 (SP1045): Validation study of the aggression diary
Characterizing underserved populations participating in the autism treatment network: Evaluating disparity through demographic influnces
PHARM- A 6-Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasido
PHARM - Essential Oils for Enhancing Quality of Life for Children in Autism Spectrum Disorder (ASD)
PHARM - An extension study to evaluate the safety and effectiveness of lurasidone in subjects with schizophrenia and autistic associated irritability
PHARM - Clonidine for Sleep Disturbances in Children with Autism Spectrum Disorder
PHARM - Disparities of Underserved Populations in the Autism Treatment network
PHARM - Essential Oils for Enhancing Quality of Life for Children in Autism Spectrum Disorder (ASD)
PHARM - An extension study to evaluate the safety and effectiveness of lurasidone in subjects with schizophrenia and autistic associated irritability
PHARM - Av1ation Study
PHARM - Clonidine for Sleep Disturbance in Children with ASD
PHARM - Av1ation Study
PHARM - Essential Oils for Enhancing Quality of Life for Children in Autism Spectrum Disorder (ASD)
PHARM - Development and Validation of a Diagnostic Interview Schedule to Assess Psychopathology in Youth with Intellectual Disabilities
PHARM -PDI-AID Study - Development and Validation of a Diagnostic Interview Schedule to Assess Psychopathology in Youth with Intellectual Disabilities
PHARM - Av1ation Study
PHARM - Essential Oils for Enhancing Quality of Life for Children in Autism Spectrum Disorder (ASD)
PHARM - Av1ation Study
PHARM - Essential Oils for Enhancing Quality of Life for Children in Autism Spectrum Disorder (ASD)
PHARM -DIAAID - Development and Validation of a Diagnostic Interview Schedule to Assess Psychopathology in Youth with Intellectual Disabilities
A PHASE II MULTICENTER, RANDOMIZED, DOUBLE-BLIND, 12-WEEK TREATMENT, 3-ARM, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFE
PHARM -DIAAID - Development and Validation of a Diagnostic Interview Schedule to Assess Psychopathology in Youth with Intellectual Disabilities
PHARM - Av1ation Study
Linked Products

PHARM - Correlates and risk markers for sleep disturbance in participants of the Autism Treatment Network.
PHARM - Evaluating Sleep Measurement in Children with Autism Spectrum Disorder: A Comparison of Actigraphy Data and Parent Report
Developing the Diagnostic Interview for Adolescent and Adults with Intellectual Disabilities: An interview schedule of mental disorders (DIAAID)